RhumbLine Advisers’s Zentalis Pharmaceuticals ZNTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-84,542
| Closed | -$134K | – | 4276 |
|
|
2025
Q1 | $134K | Sell |
84,542
-7,672
| -8% | -$12.2K | ﹤0.01% | 3289 |
|
|
2024
Q4 | $279K | Buy |
92,214
+5,501
| +6% | +$16.7K | ﹤0.01% | 3032 |
|
|
2024
Q3 | $319K | Sell |
86,713
-7,500
| -8% | -$27.6K | ﹤0.01% | 2989 |
|
|
2024
Q2 | $385K | Buy |
94,213
+11,451
| +14% | +$46.8K | ﹤0.01% | 2845 |
|
|
2024
Q1 | $1.3M | Buy |
82,762
+1,962
| +2% | +$30.9K | ﹤0.01% | 2109 |
|
|
2023
Q4 | $1.22M | Sell |
80,800
-70
| -0.1% | -$1.06K | ﹤0.01% | 2149 |
|
|
2023
Q3 | $1.62M | Buy |
80,870
+14,070
| +21% | +$282K | ﹤0.01% | 1962 |
|
|
2023
Q2 | $1.88M | Buy |
66,800
+2,093
| +3% | +$59K | ﹤0.01% | 1939 |
|
|
2023
Q1 | $1.11M | Buy |
64,707
+6,730
| +12% | +$116K | ﹤0.01% | 2072 |
|
|
2022
Q4 | $1.17M | Buy |
57,977
+3,120
| +6% | +$62.9K | ﹤0.01% | 2048 |
|
|
2022
Q3 | $1.19M | Buy |
54,857
+9,173
| +20% | +$199K | ﹤0.01% | 2047 |
|
|
2022
Q2 | $1.28M | Buy |
45,684
+7,761
| +20% | +$218K | ﹤0.01% | 2016 |
|
|
2022
Q1 | $1.75M | Buy |
37,923
+2,475
| +7% | +$114K | ﹤0.01% | 1885 |
|
|
2021
Q4 | $2.98M | Buy |
35,448
+782
| +2% | +$65.7K | ﹤0.01% | 1666 |
|
|
2021
Q3 | $2.31M | Buy |
34,666
+2,776
| +9% | +$185K | ﹤0.01% | 1825 |
|
|
2021
Q2 | $1.7M | Buy |
31,890
+1,281
| +4% | +$68.2K | ﹤0.01% | 2021 |
|
|
2021
Q1 | $1.33M | Sell |
30,609
-1,848
| -6% | -$80.2K | ﹤0.01% | 2079 |
|
|
2020
Q4 | $1.69M | Buy |
32,457
+20,347
| +168% | +$1.06M | ﹤0.01% | 1926 |
|
|
2020
Q3 | $396K | Sell |
12,110
-1,031
| -8% | -$33.7K | ﹤0.01% | 2396 |
|
|
2020
Q2 | $631K | Buy |
+13,141
| New | +$631K | ﹤0.01% | 2242 |
|